In the BioHarmony Drug Report Database
Velmanase alfa
Lamzede (velmanase alfa) is an enzyme pharmaceutical. Velmanase alfa was first approved as Lamzede on 2018-03-23. It has been approved in Europe to treat alpha-mannosidosis.
Trade Name
|
Lamzede |
|---|---|
Common Name
|
velmanase alfa |
ChEMBL ID
|
CHEMBL4298010 |
Indication
|
alpha-mannosidosis |
Drug Class
|
Enzymes |
Image (chem structure or protein)
